BPC-157 in Inflammatory Bowel Disease (IBD) In ulcerative colitis and Crohns disease models, BPC-157 has: Reduced mucosal damage and bleeding Lowered inflammation markers Promoted rapid tissue healing Minimized recurrence of flare-ups 4
doi: 10.1210/en.2011-1443 33 DicksonSLShiraziRHHanssonCBergquistFNissbrandtHSkibickaKP
patent expires in 2032.
Animal Study: Multi-Organ Protection PMC (2021) Rat study shows BPC157 protects liver, kidney, lung during ischemia-reperfusion
The balance of benefits and risks associated with weight-loss drugs may be less favorable for older people than the younger ones, making it necessary to study further how these drugs work for people aged 65 and older, they write
| Ortho and Wellness FAK-paxillin, , WADA 4Tendon, Ligament, and Muscle Injury Therapy with BPC 157 | MDPI Pharmaceuticals BPC-157 '- ', 5Regeneration or Risk